Kienbaum Peter, Heuter Thorsten, Scherbaum Norbert, Gastpar Markus, Peters Jürgen
Abteilung für Anästhsiologie und Intensivmedizin, Universitätsklinikum Essen, Germany.
J Cardiovasc Pharmacol. 2002 Sep;40(3):363-9. doi: 10.1097/00005344-200209000-00005.
In opioid addicted patients, respiratory regulation adapts allowing intake of otherwise lethal dosages of opioids. In contrast, little is known about cardiovascular regulation during chronic opioid receptor stimulation. We previously demonstrated that chronic mu-opioid receptor stimulation by methadone decreases resting muscle sympathetic activity (MSA). However, for short-term control of arterial blood pressure autonomic responses to arterial hypotension may be of greater importance. Accordingly, we tested the hypothesis that chronic opioid receptor stimulation attenuates muscle sympathetic and heart rate responses to arterial hypotension. Ten young patients (mean +/- SD, 30 years +/- 6) with a long history of mono-opioid addiction and under oral methadone substitution therapy (54 mg d(-1) +/- 31) for 12 months (+/-20) were studied. Peroneal MSA (microneurography) and heart rate responses to hypotensive challenges (sodium nitroprusside) were assessed in the awake state and compared with those of 10 matched healthy subjects. Effects of mu-opioid receptor blockade by naloxone (12.4 mg i.v.) were determined during propofol anesthesia. Chronic mu-opioid receptor stimulation markedly decreased the MSA response to hypotension (-0.5 units mm Hg(-1) +/- 0.2 vs. -2.0 +/- 1.8; p = 0.01) compared with healthy subjects despite similar arterial blood pressure and heart rate at rest. In contrast, the heart rate response to hypotension did not differ between addicted patients (6 ms mm Hg(-1) +/- 2) and healthy subjects (7 ms mm Hg(-1) +/-4). Opioid receptor blockade during propofol anesthesia markedly increased the MSA response to hypotension even beyond awake values (-1.2 units mm Hg(-1) +/- 1.1; p = 0.02 vs. awake) while the heart rate response remained unchanged. Thus, chronic mu-opioid receptor stimulation 1) results in uncompensated depression of cardiovascular sympathetic neural regulation, and 2) exerts differential effects on efferent sympathetic nerve activity to muscle and on heart rate control in response to arterial hypotension.
在阿片类药物成瘾患者中,呼吸调节会发生适应性变化,从而能够摄入原本会致命剂量的阿片类药物。相比之下,关于慢性阿片受体刺激期间的心血管调节却知之甚少。我们之前证明,美沙酮对μ-阿片受体的慢性刺激会降低静息肌肉交感神经活动(MSA)。然而,对于动脉血压的短期控制而言,自主神经对动脉低血压的反应可能更为重要。因此,我们检验了这样一个假设,即慢性阿片受体刺激会减弱肌肉交感神经和心率对动脉低血压的反应。我们研究了10名长期单一阿片类药物成瘾且接受口服美沙酮替代治疗(54毫克·天⁻¹±31)12个月(±20)的年轻患者(平均±标准差,30岁±6岁)。在清醒状态下评估腓骨肌MSA(微神经ography)和对低血压挑战(硝普钠)的心率反应,并与10名匹配的健康受试者进行比较。在丙泊酚麻醉期间确定纳洛酮(12.4毫克静脉注射)对μ-阿片受体的阻断作用。与健康受试者相比,尽管静息时动脉血压和心率相似,但慢性μ-阿片受体刺激显著降低了对低血压的MSA反应(-0.5单位·毫米汞柱⁻¹±0.2对-2.0±1.8;p = 0.01)。相比之下,成瘾患者(6毫秒·毫米汞柱⁻¹±2)和健康受试者(7毫秒·毫米汞柱⁻¹±4)对低血压的心率反应没有差异。丙泊酚麻醉期间的阿片受体阻断显著增加了对低血压的MSA反应,甚至超过清醒时的值(-1.2单位·毫米汞柱⁻¹±1.1;与清醒时相比,p = 0.02),而心率反应保持不变。因此,慢性μ-阿片受体刺激1)导致心血管交感神经调节的无代偿性抑制,并且2)对传出交感神经对肌肉的活动以及对动脉低血压的心率控制产生不同的影响。